This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Leboulleux S et al. (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61: 299–310
Messa P et al. (1995) The calcitonin–calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Transplant 10: 2259–2265
Karanikas G et al. (2004) Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89: 515–519
Costante G et al. (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92: 450–455
Papi G et al. (2006) Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29: 427–437
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Meyrier, A. What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?. Nat Rev Nephrol 3, 246–247 (2007). https://doi.org/10.1038/ncpneph0464
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0464